Brentuximab vedotin

Definition: Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL. source: Wikipedia

ID

713395006

ID date

20 Apr 2018

Previous ID

21307911000001104

Name

Brentuximab vedotin